Advertisement
Advertisement
ABEO
Abeona Therapeutics Inc. Common Stock
2.46
USDSponsored
-0.08
-3.35%
Nov 10, 15:59 UTC -5
Closed
After-Market
2.53
+0.08
+3.22%
Abeona Therapeutics Inc. Common Stock (ABEO) Earnings
ABEO Earnings Reports
Positive Surprise Ratio
ABEO beat 23 of 43 last estimates.
53%
Next Report
Next Week
Date of Next Report
Nov 16, 2026
Estimate for Q3 26 (Revenue/ EPS)
$16.81M
/-$0.15
Implied change from Q2 26 (Revenue/ EPS)
+47.74%
/-57.14%
Implied change from Q3 25 (Revenue/ EPS)
--
/+50.00%
Abeona Therapeutics Inc. Common Stock earnings per share and revenue
On Aug 13, 2026, ABEO reported earnings of -0.35 USD per share (EPS) for Q2 26, missing the estimate of -0.23 USD, resulting in a -49.19% surprise. Revenue reached 11.38 million, compared to an expected 12.48 million, with a -8.84% difference. The market reacted with a -14.95% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 16.81 million USD, implying an decrease of -57.14% EPS, and increase of 47.74% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kura Oncology, Inc.
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.83
Actual
-$0.78
Surprise
+7.00%
Olema Pharmaceuticals, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.63
Actual
-$0.73
Surprise
-14.53%
Autolus Therapeutics plc - ADR
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.16
Actual
-$0.21
Surprise
-27.20%
Protalix BioTherapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.03
Actual
$0.05
Surprise
+265.02%
PepGen Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.19%
Humacyte, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.07
Surprise
+22.91%
Seer, Inc. Class A Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.25
Surprise
+1.96%
Scholar Rock Holding Corporation Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.81
Surprise
+6.18%
TELA Bio, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.16
Actual
-$0.13
Surprise
+20.54%
Atossa Therapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.90
Actual
-$0.56
Surprise
+38.31%
FAQ
What were Abeona Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Abeona Therapeutics Inc. Common Stock reported EPS of -$0.35, missing estimates by -49.19%, and revenue of $11.38M, -8.84% below expectations.
How did the market react to Abeona Therapeutics Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -14.95%, changed from $7.46 before the earnings release to $6.34 the day after.
When is Abeona Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 16, 2026.
What are the forecasts for Abeona Therapeutics Inc. Common Stock's next earnings report?
Based on 6
analysts, Abeona Therapeutics Inc. Common Stock is expected to report EPS of -$0.15 and revenue of $16.81M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.